A growing trend in maintaining a youthful appearance through cosmetic procedures, particularly non-surgical injectables like facial fillers, is raising significant safety concerns in India, with a notable increase in cases of vision loss and other serious complications.
The Chenab Times has learned that India is rapidly becoming a major destination for aesthetic procedures, with millions of procedures performed annually, a substantial portion involving injectables such as hyaluronic acid fillers and Botulinum toxin. While these treatments are widely sought after for their perceived benefits in facial rejuvenation, a growing body of medical evidence highlights the critical risks associated with them, including irreversible blindness.
Rising Incidence of Vision Loss
Recent studies and reports indicate a dramatic surge in blindness linked to cosmetic filler injections, particularly those administered in the forehead region. Research published in the Aesthetic Surgery Journal by Beleznay and colleagues documented a significant rise in irreversible blindness cases, with further reports from the American Academy of Ophthalmology detailing hundreds of incidents. A substantial majority of these cases, approximately 83 per cent, were attributed to hyaluronic acid fillers, with an additional 15 per cent linked to autologous fat injections. The severity of these complications is underscored by the observation of stroke-like features in a significant percentage of affected individuals.
The temporal evolution of these reported cases shows a marked increase between 2018 and 2023, with hundreds of new instances of partial or complete blindness emerging during this period. This trend suggests a growing problem that requires urgent attention from both medical professionals and the public. The specific areas of the face where these complications are most frequently observed include the nasal region, the glabella (the area between the eyebrows), the forehead, and the nasolabial folds (lines running from the nose to the mouth). These zones are identified as “danger zones” due to the intricate network of blood vessels that directly supply the eyes, increasing the risk of filler material migrating into the ocular arteries.
Understanding the Danger Zones and Risks
The anatomical connections between facial arteries and the blood supply to the eyes make certain injection sites particularly hazardous. When filler material is injected into or near these critical vascular pathways, there is a high probability of retrograde embolisation, where the filler particles travel backward against the blood flow, leading to obstruction. This obstruction can cause severe damage to the retina and optic nerve, resulting in partial or total vision loss.
Injecting fat for aesthetic enhancement, such as to address sunken dark circles under the eyes, is identified as carrying one of the highest risks for blindness. Experts emphasize that such procedures demand exceptional precision, a deep understanding of facial anatomy, and extensive training, making them suitable only for highly qualified plastic surgeons. The use of fillers, even for seemingly minor aesthetic adjustments, requires meticulous technique and a thorough awareness of the potential catastrophic outcomes.
Regulatory Landscape and Uncertified Operators
In response to the inherent risks associated with injectables, regulatory bodies have taken steps to classify these products appropriately. The Central Drugs Standard Control Organisation (CDSCO) in India has banned the marketing of injectables purely as cosmetics, reclassifying them as medical devices. Soft tissue fillers, in particular, are designated as Class C devices, indicating a moderate to high level of risk. Consequently, their use is restricted to certified aesthetic surgeons and dermatologists. Official distributors are mandated by CDSCO guidelines to supply these products exclusively to certified clinics, aiming to prevent their diversion to unregulated channels.
Despite these regulations, a significant challenge remains the prevalence of uncertified salon operators and wellness clinics across India that continue to offer injectable filler treatments. These establishments often procure products through unofficial “grey market” channels, bypassing quality control and regulatory oversight. The volume of procedures performed by these unregulated entities is estimated to be substantial, potentially matching or even exceeding that of certified clinics. This widespread practice significantly amplifies the risk to consumers who may be unaware of the unlicensed nature of the services being offered and the potential dangers involved.
Recommendations for Consumers
Consumers seeking cosmetic facial enhancement procedures are strongly advised to exercise extreme caution. It is imperative to verify the credentials of the practitioner and the certification of the clinic before undergoing any injectable filler treatment. A key indicator of a reputable establishment is its preparedness for managing potential complications. This includes having a pre-arranged system for prompt access to an ophthalmologist and ensuring the clinic is equipped with the necessary protocols and emergency medical kits to manage acute adverse events, such as sudden vision loss.
While official data on the exact number of cases of blindness resulting from aesthetic injections in India is not systematically collected, anecdotal evidence and international studies suggest that the problem is significant. The ISAPS report indicated that a substantial proportion of aesthetic procedures in India occur in private clinics or smaller hospitals, suggesting a diverse and sometimes less regulated landscape for these treatments. The growth in the dermal fillers market, estimated to be worth millions of dollars, further underscores the popularity and the associated risks that need careful management.
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk
